Can Biometrics Solve the Refugee Debate?
By Katie Worth,
PBS Frontline
| 12. 02. 2015
Untitled Document
Of all the doors into the United States, the one that refugees must pass through is perhaps the most closely guarded of all: The years-long application process involves long interviews, background checks and health screenings. Refugees’ inked fingerprints are checked against databases maintained by the FBI, the Department of Defense and the Department of Homeland Security.
New developments in biometrics may add yet more steps to this process: An eyeball scan is likely to become protocol within weeks, and Homeland Security is developing a quick-turnaround DNA test that can be used in field offices.
These technological advances are arriving just as the ongoing refugee crisis in Europe and last month’s deadly attack on Paris has stirred a national debate over whether the U.S. should accept refugees from Syria. Already, more than two dozen U.S. governors have said they do not want Syrian refugees to relocate into their states. And following the attack, a bipartisan majority in the House passed legislation that would require the Department of Homeland Security, the Director of National Intelligence and the FBI to each sign off on security clearances for...
Related Articles
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...
By Hannah Devlin, The Guardian | 12.06.2025
Couples undergoing IVF in the UK are exploiting an apparent legal loophole to rank their embryos based on genetic predictions of IQ, height and health, the Guardian has learned.
The controversial screening technique, which scores embryos based on their DNA...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...
By Vardit Ravitsky, The Hastings Center | 12.04.2025
Embryo testing is advancing fast—but how far is too far? How and where do we draw the line between preventing disease and selecting for “desirable” traits? What are the ethical implications for parents, children, clinicians, and society at large? These...
